Published in Curr Pharmacol Rep on January 16, 2016
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer (2002) 28.11
Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell (1986) 20.08
Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer (2003) 15.17
Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer (2003) 8.06
How MAP kinases are regulated. J Biol Chem (1995) 6.04
NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev (2012) 5.77
Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue. Science (2001) 5.12
The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol (2009) 4.61
Signal transduction through NF-kappa B. Immunol Today (1998) 4.54
Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res (2008) 4.29
The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer (2013) 4.20
Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol (1995) 3.45
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr (2005) 3.45
The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell (1993) 3.35
Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol (2011) 2.74
Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res (2001) 2.69
Flavonoids are scavengers of superoxide anions. Biochem Pharmacol (1988) 2.65
Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) (2011) 2.62
Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther (2009) 2.50
Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev (2009) 2.14
Prostanoids in health and disease. J Lipid Res (2008) 2.06
Perspectives for cancer prevention with natural compounds. J Clin Oncol (2009) 1.99
The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia. Blood (2007) 1.99
NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev (2002) 1.97
STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene (2004) 1.96
Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res (2010) 1.82
Cancer genetics of epigenetic genes. Hum Mol Genet (2007) 1.72
RelB forms transcriptionally inactive complexes with RelA/p65. J Biol Chem (2003) 1.63
A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem Toxicol (2012) 1.56
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. Cancer Prev Res (Phila) (2013) 1.53
Green tea and incidence of colorectal cancer: evidence from prospective cohort studies. Nutr Cancer (2012) 1.47
[6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene (2005) 1.46
Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins. J Biol Chem (2001) 1.44
Extensive characterization of NF-κB binding uncovers non-canonical motifs and advances the interpretation of genetic functional traits. Genome Biol (2011) 1.40
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol (2010) 1.37
Cellular signaling perturbation by natural products. Cell Signal (2009) 1.36
Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis (2006) 1.34
Epigenetic diet: impact on the epigenome and cancer. Epigenomics (2011) 1.33
Upper aerodigestive tract cancers. Cancer (1995) 1.32
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics (2011) 1.31
Mitogen-activated protein kinases in hepatocellular carcinoma development. Semin Cancer Biol (2010) 1.29
Potential of spice-derived phytochemicals for cancer prevention. Planta Med (2008) 1.28
Mitogen-activated protein kinases and their role in radiation response. Genes Cancer (2013) 1.26
[6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res (2009) 1.26
Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. Int J Radiat Oncol Biol Phys (2009) 1.26
Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One (2012) 1.26
Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. J Immunol (1999) 1.23
Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res (2006) 1.18
Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog (2008) 1.17
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. Mol Carcinog (2011) 1.16
Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α. Carcinogenesis (2011) 1.13
Cancer chemoprevention by targeting the epigenome. Curr Drug Targets (2011) 1.13
Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling. Neoplasia (2010) 1.12
Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. Pharmacol Res (2012) 1.10
Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways. PLoS One (2013) 1.10
Green tea consumption and colorectal cancer risk: a report from the Shanghai Men's Health Study. Carcinogenesis (2011) 1.08
The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis. Invest New Drugs (2009) 1.08
Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev (2007) 1.08
Primary and secondary prevention of colorectal cancer. Clin Med Insights Gastroenterol (2014) 1.07
Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats. Jpn J Cancer Res (1992) 1.06
Dynamics and non-canonical aspects of JAK/STAT signalling. Eur J Cell Biol (2011) 1.05
Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J Nutr Biochem (2005) 1.05
Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents. J Biol Chem (2010) 1.05
Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells. Mol Carcinog (2011) 1.05
Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer. Mol Carcinog (2009) 1.03
Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study. Am J Clin Nutr (2012) 1.02
Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3. Cancer Prev Res (Phila) (2009) 1.02
Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese Health Study. Carcinogenesis (2007) 1.01
Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism. Mol Cancer Ther (2008) 0.98
Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral Oncol (2003) 0.98
Epigenetics Offer New Horizons for Colorectal Cancer Prevention. Curr Colorectal Cancer Rep (2012) 0.97
Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-κB signaling. Mol Carcinog (2011) 0.96
Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc Natl Acad Sci U S A (1996) 0.96
Health-promoting effects of green tea. Proc Jpn Acad Ser B Phys Biol Sci (2012) 0.96
The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo. Pancreas (2013) 0.94
Role of epigenetics in cancer initiation and progression. Adv Exp Med Biol (2011) 0.93
Epigenetic regulation of gene expression as an anticancer drug target. Curr Cancer Drug Targets (2011) 0.93
Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort. Ann Epidemiol (2009) 0.93
Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro. Phytother Res (2009) 0.93
[6]-Gingerol Prevents Disassembly of Cell Junctions and Activities of MMPs in Invasive Human Pancreas Cancer Cells through ERK/NF- κ B/Snail Signal Transduction Pathway. Evid Based Complement Alternat Med (2013) 0.91
Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells. Mol Nutr Food Res (2010) 0.91
Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells. World J Gastroenterol (2005) 0.91
Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6-shogaol and 6-gingerol. Mol Nutr Food Res (2012) 0.90
Nimbolide, a neem limonoid abrogates canonical NF-κB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells. Eur J Pharmacol (2012) 0.90
Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. Pharm Res (2007) 0.90
Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells. Br J Nutr (2012) 0.89
The epidemiology of tea consumption and colorectal cancer incidence. J Nutr (2003) 0.89
Silibinin suppresses TNF-alpha-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway. Molecules (2009) 0.88
Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate. Exp Cell Res (2014) 0.88
Chemopreventive effect of dietary curcumin on inflammation-induced colorectal carcinogenesis in mice. Mol Nutr Food Res (2010) 0.87
(-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Int J Oncol (2012) 0.86
Cancer chemoprevention: successes and failures. Clin Chem (2012) 0.86
Primary prevention of colorectal cancer: myth or reality? World J Gastroenterol (2014) 0.86
Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate. Carcinogenesis (2008) 0.85
Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells. Anticancer Res (2013) 0.85
Role of inflammation and inflammatory mediators in colorectal cancer. Trans Am Clin Climatol Assoc (2014) 0.85
Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice. J Nutr (2014) 0.84
(-)-Epigallocatechin-3-gallate, a green tea-derived catechin, synergizes with celecoxib to inhibit IL-1-induced tumorigenic mediators by human pancreatic adenocarcinoma cells Colo357. Eur J Pharmacol (2012) 0.83